Volume 5 Supplement 1

Institut Pasteur International Network Annual Scientific Meeting

Open Access

Klebsiella pneumoniae related community-acquired acute lower respiratory infections in CAMBODIA: clinical characteristics and treatment

  • Blandine Rammaert1Email author,
  • Sophie Goyet1,
  • Julien Beauté1,
  • Sopheak Hem2,
  • Vantha Te3,
  • Patrich Lorn Try4,
  • Charles Mayaud5,
  • Laurence Borand1,
  • Philippe Buchy6,
  • Bertrand Guillard2 and
  • Sirenda Vong1
BMC Proceedings20115(Suppl 1):P72

https://doi.org/10.1186/1753-6561-5-S1-P72

Published: 10 January 2011

In many Asian countries, Klebsiella pneumoniae is the second pathogen responsible for community-acquired pneumonia and, as other Gram negative bacilli, might produce extended spectrum β-lactamases (ESBL). Still, very little is known about K. pneumoniae implication in acute lower respiratory infections (ALRI) in Cambodia. Here we describe the clinical and radiological features of Cambodian patients presenting with community-acquired K. pneumoniae ALRI, for which antibiotics and relevant clinical outcomes were recorded. Through ALRI surveillance in 2 provincial hospitals, K. pneumoniae was identified on sputum and blood cultures and confirmed by API20E gallery from adult patients with respiratory symptoms≤14 days. Patients with known tuberculosis or immunodepression were excluded. Clinical, radiological and microbiological data were recorded and patient’s outcome was investigated after hospital discharge. A multivariate analysis of risk factors compared K. pneumoniae-infected and Haemophilus influenzae/Streptococcus pneumoniae-infected patients, 2 of the main ALRI-related pathogens in Cambodia, adjusted for the following variables: sex, tobacco, alcohol intake, cardiovascular disease, chronic lung disease, diabetes, hepatopathy, no prior treatment, hemoptysis, severity.

During April 2007-December 2009, among 3545 patients enrolled in surveillance, 47 K. pneumoniae ALRI were diagnosed in sputum (97.8%) and blood (2.1%) cultures, representing 7.7% (n=47/608) of identified bacterial etiology. The median age was 55 years (25-79) and 68.1% were females, including 75% postmenopausal women. Of the 43 available X-rays, 30 showed pneumonia (10 were necrotizing), 2 pleurisies and 11 infections on pulmonary sequelae. Severity was determined in 5 patients, 4 having pneumonia. The main known risk factors were previous medication (42.5%), chronic lung diseases (23.4%) and tobacco (21.3%); 10 patients were co-infected with a virus and 5 with tuberculosis. Producing-ESBL strains were found in 17.0% (n=8/47) of the cases, including 4 in pneumonia cases; most of those being sensitive to ciprofloxacin (n=7/8). An appropriate antibiotherapy according to the antibiogram was given to 13 patients (28%). Overall mortality was 40% (7 lost of-follow-up), higher during hospitalization and within a month after discharge.

When compared with patients presenting with S. pneumoniae and H. influenzae ALRI, K pneumoniae related ALRI were associated with female gender, prior treatment and severity on admission. In conclusion, K. pneumoniae related ALRI in Cambodia are often fatal, affect mostly women, and must be considered in patients hospitalized with severity criteria. The frequency of ESBL strains is extremely high among our infected patients. This is alarming in the context of high antibiotics intake often inappropriate and in absence of microbiology capacity in most public-sector hospitals.

Declarations

Acknowledgements

Supported by the French Development Agency through the Surveillance and Investigation of Epidemic Situations in Southeast Asia (SISEA) project.

Authors’ Affiliations

(1)
Epidemiology and Public Health Unit, Institut Pasteur in Cambodia
(2)
Biomedical Laboratory, Institut Pasteur in Cambodia
(3)
Pediatric Department, Donkeo Provincial Hospital
(4)
Pediatric Department, Provincial Hospital
(5)
Pneumology and Intensive Care Unit, Hôpital Tenon
(6)
Virology Unit, Institut Pasteur in Cambodia

Copyright

© Rammaert et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement